Aptose Biosciences
APTO
#10566
Rank
S$5.6 M
Marketcap
S$2.20
Share price
0.00%
Change (1 day)
-45.20%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -S$27.81 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$32.42 Million, an increase over its 2023 earnings that were of -S$67.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$27.81 Million-14.24%
2024 -S$32.42 Million-51.82%
2023 -S$67.29 Million22.9%
2022 -S$54.76 Million-34.91%
2021 -S$84.12 Million17.36%
2020 -S$71.68 Million107.65%
2019 -S$34.52 Million-7.73%
2018 -S$37.41 Million160.68%
2017 -S$14.36 Million-20.27%
2016 -S$18 Million28.71%
2015 -S$13.99 Million
2013 -S$7.93 Million
2010 -S$6.76 Million-8.31%
2009 -S$7.37 Million
2006 -S$13.66 Million-156.93%
2005 S$23.98 M-185.16%
2004 -S$28.16 Million458.58%
2003 -S$5.05 Million-63.66%
2002 -S$13.88 Million-8.04%
2001 -S$15.09 Million16.73%
2000 -S$12.93 Million294.99%
1999 -S$3.28 Million-6.51%
1998 -S$3.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-S$80.69 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-S$86.77 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-S$43.73 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA